4-Chloro-6-ethyl-2-methylthieno[2,3-d]pyrimidine

Catalog No. :
ACLKBF174
CAS No. :
152998-85-1
Molecular Formula :
C9H9ClN2S
Molecular Weight :
212.71

IUPAC Name:4-chloro-6-ethyl-2-methylthieno[2,3-d]pyrimidine

4-Chloro-6-ethyl-2-methylthieno[2,3-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$98.00Login to see priceIn stockInquiry
100mg95%$159.00Login to see priceIn stockInquiry
250mg95%$264.00Login to see priceIn stockInquiry
1g95%$527.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloro-6-ethyl-2-methylthieno[2,3-d]pyrimidine
IUPAC Name4-chloro-6-ethyl-2-methylthieno[2,3-d]pyrimidine
MDL No.MFCD07758958
Molecular FormulaC9H9ClN2S
Molecular Weight212.71
SMILESCC1=NC(Cl)=C(C=C(CC)S2)C2=N1
InChI KeyMLNSNVDZJYXEMZ-UHFFFAOYSA-N
Synonym4-chloro-6-ethyl-2-methylthieno[2,3-d]pyrimidine;Thieno[2,3-d]pyrimidine, 4-chloro-6-ethyl-2-methyl-;4-Chloro-6-ethyl-2-methylthieno[2,3-d]pyrimidine
CAS No.152998-85-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLKBF174 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBFTM260 route compound structure diagram
    ACBFTM26056843-79-9 In Stock
  4. Then
  5. ACLKBF174 route product structure diagram
    ACLKBF174152998-85-1 In Stock
Inquiry

2. ACLKBF174 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLKBF174 route product structure diagram
    ACLKBF174152998-85-1 In Stock
Inquiry

Comments (0)